The Lancet Infectious DiseasesImmunologyPeer-reviewed journal article
Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1
Jingyi LiuiD, Yuanling YuiD, Sijie YangiD, Fanchong JianiD, Weiliang Song, Lingling YuiD, Fei ShaoiD, Yunlong CaoiD
Abstract
XEC and KP.3.1.1 have surpassed KP.3 to become the globally dominant lineages due to their unique NTD mutations. However, several emerging JN.1 sublineages, such as LF.7.2.1, MC.10.1, NP.1, and, especially, LP.8.1, have demonstrated superior growth advantages compared to XEC. It is critical to access the virological and antigenic characteristics of these emerging SARS-CoV-2 variants. Here, we found that LF.7.2.1 is significantly more immune invasive than XEC, primarily due to the A475V mutation, which enabled the evasion of Class 1 neutralizing antibodies. However, LF.7.2.1s weak ACE2 binding affinity substantially impaired its fitness. Likewise, MC.10.1 and NP.1 exhibited strong antibody immune evasion due to the A435S mutation, but their limited ACE2 engagement efficiency restricted their growth advantage, suggesting that A435S may regulate the Spike conformation, similar to the NTD glycosylation mutations found in KP.3.1.1 and XEC. Most importantly, we found that LP.8.1 showed comparable humoral immune evasion to XEC but demonstrated much increased ACE2 engagement efficiency, supporting its rapid growth. These findings highlight the trade-off between immune evasion and ACE2 engagement efficiency in SARS-CoV-2 evolution, and underscore the importance of monitoring LP.8.1 and its descend lineages.
- Citations
- 48
- FWCI
- 32.05
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants
Ian A. Mellis, Madeline Wu, … David D. Ho·Cell ReportsPeer-reviewed·Nov 24, 2025
- Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1
Caiwan Guo, Yuanling Yu, … Yunlong Cao·The Lancet Infectious DiseasesPeer-reviewed·Jun 5, 2025
- Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
Qian Wang, Yicheng Guo, … David D. Ho·Cell ReportsPeer-reviewed·Apr 1, 2025
- Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
- Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Qian Wang, Ian A. Mellis, … Lihong Liu·Emerging Microbes & InfectionsPeer-reviewed·Sep 11, 2024
- Antibody evasion and receptor binding of SARS-CoV-2 RW.1.1
Kristin Daniel, Hsiang Hong, … Ian A. Mellis·bioRxiv·Sep 18, 2026